Blog

(From : http://feeds.feedburner.com - October 19 , 2017 )

Every trade secret case is built around a story. Sure, the plaintiff’s story is different than the defendant’s, even though each draws on the same facts. For the rest of us that don’t have a dog in the fight, helpful lessons are available.

(From : http://docketreport.blogspot.com - October 18 , 2017 )

Following a jury trial, appeal, and retrial, the court granted in part plaintiff's motion for enhanced damages and enhanced the jury's verdict by 50% because defendant's lack of a good faith belief of noninfringement, lack of closeness of the cas

(From : http://docketreport.blogspot.com - October 18 , 2017 )

Following summary judgment of noninfringement, the court denied defendants' motion for attorney fees under 35 U.S.C. § 285 and rejected defendants' argument that deterrence was necessary to protect other generic drug manufacturers.

(From : http://feeds2.feedburner.com - October 18 , 2017 )

It had been a bad three months for Allergan, Inc. The drug maker’s stock price had fallen over 20 percent, as the company faced two legal challenges to the patents on its blockbuster drug, Restasis.

(From : http://www.ip-watch.org - October 18 , 2017 )

It had been a bad three months for Allergan, Inc. The drug maker’s stock price had fallen over 20 percent, as the company faced two legal challenges to the patents on its blockbuster drug, Restasis.

(From : http://feeds.feedburner.com - October 18 , 2017 )

"Increasing numbers of US operating companies dislike patent protection," Ding explained to IAM. "[T]he production and manufacture of products are increasingly located in Asia and Asian companies have more and more patents...

(From : http://feeds2.feedburner.com - October 18 , 2017 )

Extended monopoly protection by the Regulation EC 469/2009 concerning the supplementary protection certificate (SPC) mechanism for medicinal products has led to spiralling prices in Europe for lifesaving medicines, while exhausting the national bu

(From : http://www.ip-watch.org - October 18 , 2017 )

Extended monopoly protection by the Regulation EC 469/2009 concerning the supplementary protection certificate (SPC) mechanism for medicinal products has led to spiralling prices in Europe for lifesaving medicines, while exhausting the national bu

(From : http://feeds.feedburner.com - October 18 , 2017 )

A major legal battle over patented technologies in the mobile device communication sector between San Diego, CA-based semiconductor developer Qualcomm Inc. and Cupertino, CA-based consumer tech giant Apple Inc.

(From : http://feeds.feedburner.com - October 18 , 2017 )

The U.S. patent promise of exclusivity has become nothing more than lip service with no credibility for more than half a century. A patent system maintained by offering lip service must fail over time.